SUGAR LAND--October 30, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--By the end of 2014, the Pharmaceutical-Biotech Industry is forecast to have begun $4.5 billion in capital and maintenance (MRO) projects. A recent survey of Industrial Info's project database returned 251 active North American projects with a total investment value (TIV) of $4.5 billion that are scheduled to begin construction during the fourth quarter of 2014. The projects are scattered throughout the North America and represent an average project TIV of $18 million.

Within this article: Details on the growing industry, including key projects from major companies such as Baxter International (NYSE:BAX), General Electric (NYSE:GE) and Bocchi Laboratories.